🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 día
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/04/2014 | 91,52 | 93,76 | 88,91 | 89,00 | -2,06% | 5,30% | 1.186.600 |
| 25/04/2014 | 93,05 | 94,60 | 90,85 | 90,87 | -2,81% | 4,03% | 544.100 |
| 24/04/2014 | 94,51 | 94,68 | 91,02 | 93,50 | -0,14% | 3,87% | 1.077.300 |
| 23/04/2014 | 96,01 | 96,66 | 93,62 | 93,63 | -2,40% | 3,17% | 749.500 |
| 22/04/2014 | 96,00 | 97,39 | 94,99 | 95,93 | -0,27% | 2,50% | 1.061.300 |
| 21/04/2014 | 96,40 | 96,84 | 94,51 | 96,19 | -0,01% | 2,42% | 608.500 |
| 17/04/2014 | 98,00 | 99,98 | 95,98 | 96,20 | -2,06% | 4,08% | 815.200 |
| 16/04/2014 | 97,29 | 98,90 | 95,95 | 98,22 | +2,20% | 3,03% | 968.800 |
| 15/04/2014 | 95,11 | 96,67 | 91,61 | 96,11 | +1,41% | 5,32% | 1.476.200 |
| 14/04/2014 | 93,66 | 96,22 | 92,98 | 94,77 | +2,14% | 3,46% | 920.000 |
| 11/04/2014 | 95,11 | 97,74 | 92,68 | 92,78 | -3,50% | 5,32% | 1.354.800 |
| 10/04/2014 | 98,05 | 98,05 | 94,57 | 96,15 | -1,97% | 3,55% | 1.527.000 |
| 09/04/2014 | 94,55 | 98,45 | 93,93 | 98,08 | +3,89% | 4,78% | 827.700 |
| 08/04/2014 | 93,35 | 95,03 | 92,01 | 94,41 | +1,14% | 3,24% | 989.400 |
| 07/04/2014 | 90,60 | 95,28 | 89,09 | 93,35 | +2,65% | 6,83% | 1.401.500 |
| 04/04/2014 | 93,86 | 94,50 | 89,79 | 90,94 | -2,45% | 5,02% | 817.300 |
| 03/04/2014 | 95,84 | 96,20 | 92,33 | 93,22 | -3,47% | 4,04% | 1.004.400 |
| 02/04/2014 | 97,78 | 99,11 | 95,22 | 96,57 | -1,24% | 3,98% | 837.800 |
| 01/04/2014 | 95,13 | 97,92 | 95,00 | 97,78 | +3,99% | 3,07% | 820.200 |
| 31/03/2014 | 87,94 | 94,30 | 87,94 | 94,03 | +3,71% | 7,23% | 855.600 |
| 28/03/2014 | 93,80 | 95,63 | 90,25 | 90,67 | -3,40% | 5,74% | 786.700 |
| 27/03/2014 | 93,51 | 95,57 | 91,34 | 93,86 | +0,26% | 4,52% | 1.062.200 |
| 26/03/2014 | 95,56 | 98,62 | 93,54 | 93,62 | -0,92% | 5,32% | 666.900 |
| 25/03/2014 | 94,47 | 98,60 | 93,49 | 94,49 | +0,40% | 5,41% | 785.300 |
| 24/03/2014 | 94,75 | 94,86 | 90,25 | 94,11 | -0,68% | 4,87% | 818.300 |
| 21/03/2014 | 96,66 | 96,66 | 92,00 | 94,75 | -1,42% | 4,82% | 1.107.800 |
| 20/03/2014 | 96,04 | 97,32 | 95,71 | 96,11 | -0,64% | 1,68% | 344.800 |
| 19/03/2014 | 98,51 | 98,82 | 96,65 | 96,73 | -1,76% | 2,20% | 415.000 |
| 18/03/2014 | 96,19 | 99,59 | 95,86 | 98,46 | +2,72% | 3,88% | 580.100 |
| 17/03/2014 | 95,26 | 97,35 | 94,46 | 95,85 | +0,94% | 3,03% | 582.000 |